New NHS centre for making products for revolutionary cell and gene therapies
NHS Blood and Transplant (NHSBT) is today [Friday, March 10] opening a state-of-the-art facility which will contribute greatly to the UK’s ability to develop and manufacture new gene and cell therapies.
It will manufacture products for the development of potentially curative therapies for currently incurable diseases, such as some forms of cancer, sickle cell disease, and cystic fibrosis. Some of these will be personalised therapies, aimed at treating just one person.
The new Clinical Biotechnology Centre (CBC), which has been built in Bristol with a near £10m Government grant, is designed to expand the UK’s ability to make the clinical grade products required for the research and development of new cell and gene therapies.
It will support early phase clinical trials and pre-clinical work, providing a route to eventual commercial scale production.
It will help give patients quick access to the latest treatments by increasing the number of UK patients with incurable diseases who are able to take part in clinical trials and also bring new treatments into the NHS faster.
Published on the 10th of March 2023. For further information follow this link.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (22 décembre 2023). New NHS centre for making products for revolutionary cell and gene therapies. ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/vez3





